retatrutide clinical trial phase retatrutide Weight Loss Treatment Explained Eli Lilly's Phase 3 clinical

In the landmark SURPASS-2 clinical trial, Mounjaro achieved A1C reductions of up to 2.3% versus 1.9% for injectable semaglutide, while producing approximately 2.5 times greater weight loss (12.4 kg vs 6.2 kg)

With the right preparation and a little patience, you can handle the reconstitution process at home

Add a small amount of difficulty every 23 weeks one more repetition, a slightly heavier band, or a more challenging variation of the exercise

Weight loss surgery typically leads to 25-35% weight loss

Payers are increasingly hesitant to cover lifelong drug treatments, emphasizing the need for effective behavior change programs